XBI
XBI
About State Street SPDR S&P Biotech ETF
The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index...
About State Street SPDR S&P Biotech ETF
The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 APLS | Apellis Pharmaceuticals, Inc. | 1.75% | 3.84M | $153.04M |
 RVMD | Revolution Medicines, Inc. | 1.58% | 964.59K | $138.21M |
 TVTX | Travere Therapeutics, Inc. | 1.53% | 3.25M | $133.29M |
 TGTX | TG Therapeutics, Inc. | 1.32% | 3.42M | $115.34M |
 TWST | Twist Bioscience Corporation | 1.31% | 2.05M | $114.70M |
 ALKS | Alkermes plc | 1.31% | 3.46M | $114.18M |
 MDGL | Madrigal Pharmaceuticals, Inc. | 1.30% | 222.53K | $113.86M |
 SMMT | Summit Therapeutics Inc. | 1.28% | 5.52M | $112.12M |
 APGE | Apogee Therapeutics, Inc. | 1.27% | 1.29M | $110.90M |
 BEAM | Beam Therapeutics Inc. | 1.25% | 3.68M | $108.77M |
 PRAX | Praxis Precision Medicines, Inc. | 1.24% | 323.50K | $108.34M |
 ARWR | Arrowhead Pharmaceuticals, Inc. | 1.23% | 1.65M | $107.45M |
 SRRK | Scholar Rock Holding Corporation | 1.23% | 2.22M | $107.42M |
 CRSP | CRISPR Therapeutics AG | 1.22% | 1.92M | $106.61M |
 PTCT | PTC Therapeutics, Inc. | 1.19% | 1.46M | $104.08M |
 KYMR | Kymera Therapeutics, Inc. | 1.18% | 1.18M | $103.20M |
 INSM | Insmed Incorporated | 1.18% | 689.02K | $103.01M |
 EXEL | Exelixis, Inc. | 1.18% | 2.30M | $102.83M |
 BBIO | BridgeBio Pharma, Inc. | 1.17% | 1.35M | $102.19M |
 NTRA | Natera, Inc. | 1.17% | 488.47K | $102.18M |
SECTOR HOLDINGS
Healthcare
Financial ServicesASSET ALLOCATION BY REGION
United States
Ireland
Switzerland
United Kingdom
NetherlandsSECTOR HOLDINGS
Healthcare Financial ServicesASSET ALLOCATION BY REGION
United States Ireland Switzerland United Kingdom NetherlandsHoldings (Top 20)
APLS
Apellis Pharmaceuticals, Inc.
RVMD
Revolution Medicines, Inc.
TVTX
Travere Therapeutics, Inc.
TGTX
TG Therapeutics, Inc.
TWST
Twist Bioscience Corporation
ALKS
Alkermes plc
MDGL
Madrigal Pharmaceuticals, Inc.
SMMT
Summit Therapeutics Inc.
APGE
Apogee Therapeutics, Inc.
BEAM
Beam Therapeutics Inc.
PRAX
Praxis Precision Medicines, Inc.
ARWR
Arrowhead Pharmaceuticals, Inc.
SRRK
Scholar Rock Holding Corporation
CRSP
CRISPR Therapeutics AG
PTCT
PTC Therapeutics, Inc.
KYMR
Kymera Therapeutics, Inc.
INSM
Insmed Incorporated
EXEL
Exelixis, Inc.
BBIO
BridgeBio Pharma, Inc.
NTRA
Natera, Inc.